TY - JOUR
T1 - Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement
AU - Francis, Charles W.
AU - Pellegrini, Vincent D.
AU - Leibert, Kristin M.
AU - Totterman, Saara
AU - Azodo, Michael V.
AU - Harris, Carl M.
AU - Cox, Christopher
AU - Marder, Victor J.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1996/5
Y1 - 1996/5
N2 - A prospective, randomized trial was conducted to compare the effectiveness and safety of warfarin given in two regimens in prevention of venous thrombosis after total knee replacement. Adult patients scheduled for primary or revision total knee replacement were randomly assigned to receive either a 'two-step' warfarin regimen beginning 10-14 days pre-operatively or, alternatively, to begin warfarin the night before surgery. Post-operatively, the dose was adjusted in both groups to achieve a target International Normalized Ratio (INR) of 2.2 and prophylaxis was continued until venography on post-operative days five through nine. Bleeding was assessed by surgical blood loss, transfusion requirements, changes in hematocrit, and clinically identified bleeding complications. The occurrence of deep vein thrombosis was nearly the same in the two treatment groups, 39% in patients randomized to the two-step regimen as compared to 38% in those beginning the night before surgery. The occurrence of proximal vein thrombosis was also similar, 5% versus 7% (p = NS). Patients in the two-step group received 1.33 ± 1.26 transfusions compared to 0.95 ± 1.22 in the night before group (p < 0.05) and also had a lower nadir post-operative hematocrit of 26.7 ± 3.1 as compared to 28.5 ± 3.2 (p < 0.0001). Major bleeding complications were associated with excessively prolonged INRs and occurred in five patients in the two-step group and two in the night before group. Patients in both groups who developed thrombosis had a significantly lower INR on post-operative days two and three compared to those without thrombosis. We conclude that a prophylactic warfarin regimen for prevention of deep vein thrombosis after total knee replacement beginning the night before surgery is more convenient and may be associated with less bleeding than a regimen beginning warfarin 10-14 days pre-operatively. Careful control of anticoagulant intensity is needed to achieve maximum effectiveness and avoidance of bleeding complications.
AB - A prospective, randomized trial was conducted to compare the effectiveness and safety of warfarin given in two regimens in prevention of venous thrombosis after total knee replacement. Adult patients scheduled for primary or revision total knee replacement were randomly assigned to receive either a 'two-step' warfarin regimen beginning 10-14 days pre-operatively or, alternatively, to begin warfarin the night before surgery. Post-operatively, the dose was adjusted in both groups to achieve a target International Normalized Ratio (INR) of 2.2 and prophylaxis was continued until venography on post-operative days five through nine. Bleeding was assessed by surgical blood loss, transfusion requirements, changes in hematocrit, and clinically identified bleeding complications. The occurrence of deep vein thrombosis was nearly the same in the two treatment groups, 39% in patients randomized to the two-step regimen as compared to 38% in those beginning the night before surgery. The occurrence of proximal vein thrombosis was also similar, 5% versus 7% (p = NS). Patients in the two-step group received 1.33 ± 1.26 transfusions compared to 0.95 ± 1.22 in the night before group (p < 0.05) and also had a lower nadir post-operative hematocrit of 26.7 ± 3.1 as compared to 28.5 ± 3.2 (p < 0.0001). Major bleeding complications were associated with excessively prolonged INRs and occurred in five patients in the two-step group and two in the night before group. Patients in both groups who developed thrombosis had a significantly lower INR on post-operative days two and three compared to those without thrombosis. We conclude that a prophylactic warfarin regimen for prevention of deep vein thrombosis after total knee replacement beginning the night before surgery is more convenient and may be associated with less bleeding than a regimen beginning warfarin 10-14 days pre-operatively. Careful control of anticoagulant intensity is needed to achieve maximum effectiveness and avoidance of bleeding complications.
UR - http://www.scopus.com/inward/record.url?scp=0029905317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029905317&partnerID=8YFLogxK
U2 - 10.1055/s-0038-1650352
DO - 10.1055/s-0038-1650352
M3 - Article
C2 - 8725709
AN - SCOPUS:0029905317
SN - 0340-6245
VL - 75
SP - 706
EP - 711
JO - Thrombosis and Haemostasis
JF - Thrombosis and Haemostasis
IS - 5
ER -